HPR50 Life-YEARS Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.976
https://www.valueinhealthjournal.com/article/S1098-3015(22)01177-9/fulltext
Title : HPR50 Life-YEARS Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01177-9&doi=10.1016/j.jval.2022.04.976
First page :
Section Title :
Open access? : No
Section Order : 10881
Categories :
Tags :
Regions :
ViH Article Tags :